MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Olfactory dysfunction in Parkinson’s disease

    N. Jalami, H. Bentahar, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: It is to propose a psychophysical test of the olfactory function. Its originality is to use Moroccan odorous products belonging to our culture to…
  • 2019 International Congress

    Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication

    S. Jost, A. Sauerbier, K. Ray-Chaudhuri, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, A. Rizos, A. Schnitzler, P. Löhrer, JN. Petry-Schmelzer, M. Barbe, A. Antonini, P. Martinez-Martin, G. Fink, L. Timmermann, H. Dafsari (Cologne, Germany)

    Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms (NMS) and self-reported quality of life compared to…
  • 2019 International Congress

    Levocarb-induced diplopia in idiopathic Parkinson’s disease: a case report

    S. Joza, F. Ba (Edmonton, AB, Canada)

    Objective: To present a case report of Levocarb-induced diplopia in idiopathic Parkinson’s disease. Background: Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by a…
  • 2019 International Congress

    Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease

    W. Kamel, J. Al Hashel (Beni Suef, Egypt)

    Objective: To identify the advantages of LCIG in the treatment of NMS among APD patients and appraise the currently available literature to identify the gaps…
  • 2019 International Congress

    The influence of baseline body mass index on cognitive decline in Parkinson’s disease

    SY. Kang, HS. Yoo, SJ. Chung, YH. Sohn, PH. Lee (Seoul, Republic of Korea)

    Objective: The aim of this study is to know whether the baseline BMI is associated with cognitive decline and future development of dementia. Background: Alterations…
  • 2019 International Congress

    Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

    J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)

    Objective: To report 3 cases of drug-induced encephalopathy in patients treated with pimavanserin (PVN) for Parkinson disease (PD) related psychosis (PDP). Background: Quetiapine and clozapine,…
  • 2019 International Congress

    A Prospective Study of the Effects of Deep Brain Stimulation on Constipation and Olfaction in Parkinson Disease

    S. Kola, A. Bharucha, D. Prichard, K. Feuerhak, A. Hassan (Rochester, MN, USA)

    Objective: To investigate the effects of subthalamic nucleus deep brain stimulation (STN-DBS) on constipation and olfaction in patients with Parkinson disease (PD). Background: STN-DBS is…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s Disease

    E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

    Objective: The objective is to study the relation between cognitive impairment with the form and stage of PD. Background: Currently, there is a tendency of…
  • 2019 International Congress

    Evaluation of gut microbiota in patients with Parkinson’s disease using a gas chromatography–mass spectrometry in Russia

    I. Krasakov, I. Litvinenko (Saint-Petersburg, Russian Federation)

    Objective: To evaluat of gut microbiota in patients with Parkinson's disease using a gas chromatography–mass spectrometry Background: An increasing number of studies have reported the…
  • 2019 International Congress

    The social interaction in patients with Parkinson’s disease from the points of activities of daily living and motor function

    A. Kumon, M. Sagawa, M. Saruwatari, N. Kawashima, K. Hasegawa (Fujisawa, Japan)

    Objective: To investigate how the social interaction relates to activities of daily living (ADL) and motor function in patients with Parkinson’s disease (PD). Background: In…
  • « Previous Page
  • 1
  • …
  • 1386
  • 1387
  • 1388
  • 1389
  • 1390
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley